carmine has been researched along with Dyslipidemias in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, X; Fang, B; Ge, C; He, Y; Hu, L; Kuang, Q; Li, L; Li, Q; Tan, J; Xu, M; Xu, Q; Yan, L; Zhang, Y | 1 |
1 other study(ies) available for carmine and Dyslipidemias
| Article | Year |
|---|---|
Carminic acid mitigates fructose-triggered hepatic steatosis by inhibition of oxidative stress and inflammatory reaction.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Carmine; Disease Models, Animal; Dyslipidemias; Fructose; Hepatocytes; Inflammation; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Reactive Oxygen Species | 2022 |